Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

PURSUIT: Un Programa Escolar Tecnológicamente Mejorado para Mejorar la Afrontación Infantil y Prevenir el Consumo de Sustancias.

5 de octubre de 2026 actualizado por: Natoshia Cunningham, Michigan State University

PURSUIT: Un programa escolar tecnológicamente aumentado para mejorar el afrontamiento infantil y prevenir el consumo de sustancias.

The study investigators aim to test an online support platform for Michigan youth aged 8-18 years enrolled in elementary, middle, or high school and their parent/caregiver. The online support platform will be hosted on the Computerized Intervention Authoring System (CIAS) 3.0 and will provide evidence-based cognitive behavioral coping skills for physical (pain) and mental (stress, mood) health symptoms, with additional substance use prevention content for youth aged 12 and older. Evaluations will occur at baseline and then a post assessment approximately 8 weeks later.

Descripción general del estudio

Descripción detallada

The study investigator's aims are to:

  1. Evaluate the feasibility and acceptability of the PURSUIT online support platform using mixed methods.
  2. Explore the impact of PURSUIT on youth's physical (pain) and mental health (stress, anxiety, mood, perceived risk of substance use) symptoms at post assessment.

Consented youth will complete a baseline assessment (week 1), and then will use the PURSUIT online platform (expected duration is 6 week), and complete a post assessment (week 8).

Within the PURSUIT platform, all youth will have access to tools teaching cognitive-behavioral strategies for managing mood, anxiety, stress, and physical pain. Youth aged 12 and older will have access to additional content presenting cognitive-behavioral strategies for reducing the risk of substance use.

Youth will provide data on their symptoms (e.g thoughts, mood, behaviors, sleep, pain, and stress) at baseline and post assessment. A caregiver will report on the child's demographics, adverse childhood experience (ACE) exposure, school performance/attendance and their own mood. At post-assessment, the youth will also be asked to take part in a brief, semi-structured interview regarding their experiences with PURSUIT.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

100

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Natoshia R Cunningham, PhD
  • Número de teléfono: 845-662-6198
  • Correo electrónico: natoshia@msu.edu

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

    • Michigan
      • Grand Rapids, Michigan, Estados Unidos, 49503
        • Michigan State University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

8 años a 18 años (Niño, Adulto)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Aged eight to 18 years
  • Enrolled in a Michigan elementary, middle, or high school

Exclusion Criteria:

  • Age under 8
  • Age over 18 years
  • Non-enrollment in A Michigan school.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: PURSUIT Self-Management Portal

All youth enrolled in the study will have access to an online self-management platform, hosted by the Computerized Intervention Authoring System (CIAS). The self-management platform comprises evidence-based cognitive-behavioral psycho-education and skills broadly applicable to physical (pain) and mental (stress, mood) health symptoms. Youth aged twelve and older will have access to content related to preventing substance use. Materials include instructional videos, handouts, and worksheets.

PURSUIT is an online self-management platform for youth aged 8-18 and one caregiver that provides cognitive-behavioral coping skills for physical and mental health symptoms, plus substance use prevention content for youth aged 12 and older.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
PURSUIT Feasibility-Youth Retention
Periodo de tiempo: From baseline to post assessment, approximately 8 weeks

The percentage of youth who complete a post-assessment measure, relative to those who complete a baseline assessment.

From baseline to post assessment, approximately 8 weeks
PURSUIT Feasibility/Acceptability
Periodo de tiempo: From baseline to post-assessment, approximately 8 weeks.

Youth will complete a brief, semi-structured interview following a six-week period of engagement with the online self-management portal to assess the feasibility ("Do you think you will be able to integrate these skills into your schedule with school/work?") and acceptability of PURSUIT.

From baseline to post-assessment, approximately 8 weeks.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Changes in pain, as measured by the Pain Visual Analog Scale (VAS)
Periodo de tiempo: From baseline to post-assessment, approximately 8 weeks.

Youth will report their average pain intensity over the past two weeks using a Visual Analog Scale (VAS). Responses range from 0 (no pain) to 10 (worst imaginable pain), with ratings ≥ 3 indicating moderate pain.

From baseline to post-assessment, approximately 8 weeks.
Change in functional disability, measured using the Functional Disability Inventory (FDI)
Periodo de tiempo: From baseline to post-assessment, approximately 8 weeks.

The 15-item FDI assesses youths' difficulty performing tasks across home, school, recreational, and social settings over the "past few days" due to physical symptoms. Items are rated from 0 ("no trouble") to 4 ("impossible") and summed, yielding total scores of 0-60 with scores ≥7 suggesting greater than minimal disability

From baseline to post-assessment, approximately 8 weeks.
Changes in post-traumatic stress disorder symptoms (PTSD), measured using the UCLA Reaction Index for DSM-5 Brief Screening Form
Periodo de tiempo: From baseline to post-assessment, approximately 8 weeks.

The UCLA Reaction Index for DSM-5 Brief Screening Form is an 11-item measure of how often youth experienced psychological stress and physiological reactivity due to internal or external trauma reminders, intrusive trauma-related memories, avoidance of internal and external reminders of trauma, emotional dysregulation, attention issues, feelings of detachment, and sleep disturbance over the past month. Items are scored from zero (none of the time) to four (most of the time) and summed; scores of 11-20 suggest mild PTSD symptoms, while scores ≥21 are indicative of potential PTSD. We adapted this measure to not query the type of traumatic exposure experienced by youth. It will only be completed by those who endorse exposure (yes/no) to a frightening or upsetting event.

From baseline to post-assessment, approximately 8 weeks.
Change in anxiety symptoms, measured using the Screen for Child Anxiety Related Disorders (SCARED)
Periodo de tiempo: From baseline to post-assessment, approximately 8 weeks.

The 41-item Screen for Child Anxiety Related Disorders (SCARED) assesses past 3-month anxiety symptoms. Items are scored on a 3-point Likert-style scale (0 = not true or hardly ever true, 2=very true or often true), and summed to yield total scores of 0-82 with higher scores indicating greater anxiety and scores ≥25 suggesting clinical significance.

From baseline to post-assessment, approximately 8 weeks.
Change in depressive symptoms, measured using the PROMIS Pediatric Short Form 8a
Periodo de tiempo: From baseline to post-assessment, approximately 8 weeks.

Youth will report the frequency (1=never, 5=almost always) of past-week depressive symptoms (e.g., sadness, loneliness) using the eight-item PROMIS Pediatric Depressive Symptoms Short Form 8a. Raw summed scores (range 8 to 40) are converted to T-scores (mean 50, standard deviation 10), with T-scores >55 suggesting mild or higher symptoms.

From baseline to post-assessment, approximately 8 weeks.
Change in fatigue symptoms; as measured by the PROMIS Pediatric Short Form 10a
Periodo de tiempo: From baseline to post-assessment, approximately 8 weeks.

Past week fatigue symptoms will be self-reported by youth using the 10-item PROMIS Pediatric Short Form. Items ("Being tired made it hard for me to play or go out with my friends as much as I'd like") are rated on a 5-point Likert-style scale (1=never, 5=almost always) and summed in to total scores, which are converted into T-scores (>55 suggesting at least mild symptoms).

From baseline to post-assessment, approximately 8 weeks.
Change in sleep disturbance symptoms, measured using the PROMIS Pediatric Sleep Disturbance Short Form 8a
Periodo de tiempo: From baseline to post-assessment; approximately 8 weeks

The frequency (1=never, 5=almost always) with which youth experienced sleep disturbance symptoms (e.g., trouble falling or staying asleep) in the past week will be assessed using the eight-item PROMIS Pediatric Sleep Disturbance Short Form. T-scores (>55 indicative of mild or greater symptoms) will be derived from summed raw scores.

From baseline to post-assessment; approximately 8 weeks
Change in youths' perceived risk of substance use; measured using Monitoring The Future items
Periodo de tiempo: From baseline through post-assessment; approximately 8 weeks.

Youth age 12 and older will report how risky (1= No Risk, 4=Great Risk) they perceive different cigarette, cannabis, alcohol, or vaping use behaviors (e.g., occasional versus regular use) using 12 items from the 2023 Monitoring the Future (MTF) study. MTF is an ongoing longitudinal panel study conducted by the University of Michigan that includes annual surveys of nationally representative samples of 8th, 10,th and 12th grade youth.

From baseline through post-assessment; approximately 8 weeks.
Change in youth's substance use behaviors; assessed using the Screening to Brief Intervention (S2B1)
Periodo de tiempo: From baseline through post-assessment; approximately 8 weeks.

The frequency (never, once or twice, monthly, weekly or more often) of past-year nicotine, alcohol, cannabis, and other substance use behaviors will be assessed for youth 12 years and older using the youth-reported Screening to Brief Intervention (S2BI)

From baseline through post-assessment; approximately 8 weeks.
Changes in caregivers' depression, anxiety, and stress as measured by the Depression Anxiety and Stress Scales 21 (DASS21)
Periodo de tiempo: From baseline to post-assessment, approximately 8 weeks.

The DASS21 depression, anxiety, and stress on a scale of 0-63 with 0 indicating low levels of these feelings, and 63 indicating high levels. This measure will only be completed by caregivers.

From baseline to post-assessment, approximately 8 weeks.
Change in stress, measured by the PROMIS Pediatric Psychological Stress Experiences 8a
Periodo de tiempo: From baseline to post-assessment; approximately 8 weeks

Youth will report how often (1=never, 5=almost always) they experienced feelings of stress over the past week using the eight-item PROMIS Psychological Stress Experiences-Short Form 8a. As per other PROMIS short forms, summed scores are converted to T-scores.

From baseline to post-assessment; approximately 8 weeks
Patient Global Impression of Change
Periodo de tiempo: post-assessment; approximately 8 weeks after baseline

A single-item measure completed by the child and caregiver that assesses perceived overall change in the child's status since completing the intervention. Scores range from 1 (Very Much Improved) to 7 (Very Much Worse).

post-assessment; approximately 8 weeks after baseline

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Youth Engagement
Periodo de tiempo: From baseline to post-assessment, approximately 8 weeks

The percent of youth who complete at least one activity within the platform, relative to those who complete baseline assessments.

From baseline to post-assessment, approximately 8 weeks
Adverse Childhood Experiences (ACEs)
Periodo de tiempo: Baseline

Youth's lifetime exposure to nine ACEs (e.g., violence, household dysfunction) will be reported by caregivers (if age <18) using items adapted from the National Survey of Children's Health.

Baseline
Family Demographic Information
Periodo de tiempo: Baseline

Parents/caregivers will report youths' age, sex at birth, racial and ethnic identities, household income, health insurance status/type, and their own highest level of education at baseline.

Baseline
Youth School Attendance
Periodo de tiempo: From baseline to post-assessment; approximately 8 weeks

Parent/caregivers will report the frequency with which their child misses or is late to school due to physical and/or mental health symptoms over the past month at baseline and after engaging with the self-management platform

From baseline to post-assessment; approximately 8 weeks
Symptom status and program motivation
Periodo de tiempo: baseline

A brief intake questionnaire assessing whether participants experience pain, worries or sad feelings, and stress at baseline and their reasons for participating in the program.

baseline

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de noviembre de 2026

Finalización primaria (Estimado)

1 de marzo de 2027

Finalización del estudio (Estimado)

1 de julio de 2027

Fechas de registro del estudio

Enviado por primera vez

24 de noviembre de 2025

Primero enviado que cumplió con los criterios de control de calidad

24 de noviembre de 2025

Publicado por primera vez (Actual)

5 de diciembre de 2025

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

6 de octubre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

5 de octubre de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • STUDY00011346
  • G-2404-153994 (Otro número de subvención/financiamiento: Michigan Health Endowment Fund)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

We will not publicly share to protect participant identities but de-identified data may be made available upon reasonable request.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir